Get Live Data

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Syncona Share Price
  4. Syncona Share News
  5. IN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-cel

Pin to quick picksSyncona Share News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.00
Bid: 110.00
Ask: 110.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 110.00
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Syncona notes FDA acceptance of Autolus's BLA for obe-cel

Mon, 22nd Jan 2024 12:19

Syncona Ltd - London-based investor in healthcare companies - The US Food & Drug Administration accepts Autolus Therapeutics PLC's biologics licence application for obe-cel for patients with relapsed/refractory adult B-cell acute lymphoblastic leukaemia. The FDA has set a target action date of November 16 for reviewing the application, Syncona says. Further, Autolus is on track to submit a marketing authorisation application to the EU's European Medicines Agency in the first half of 2024.

Syncona has an 18% stake in Autolus.

Current stock price: 117.05 pence, down 0.3% on Monday

12-month change: down 31%

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
19 Dec 2019 07:53

Syncona commits $80m to Freeline

(Sharecast News) - Healthcare company Syncona said it had made an $80m (£61.1m) funding commitment to biotech company Freeline.

Read more
9 Dec 2019 09:32

Syncona upbeat on latest data from Autolus Therapeutics

(Sharecast News) - Syncona shares were just above the waterline on Monday morning, after two updates from its portfolio company Autolus Therapeutics, in which it announced new data at the American Society of Hematology (ASH) annual meeting in Orlando, Florida.

Read more
9 Dec 2019 08:31

Syncona And Arix Note Positive New Data From Portfolio Firm Autolus

Syncona And Arix Note Positive New Data From Portfolio Firm Autolus

Read more
21 Nov 2019 10:47

Syncona Adds Azeria Therapeutics To Portfolio As Net Assets Take Hit

Syncona Adds Azeria Therapeutics To Portfolio As Net Assets Take Hit

Read more
21 Nov 2019 08:34

Syncona sees negative returns as it continues to invest in portfolio firms

(Sharecast News) - Healthcare investment company Syncona reported net assets of £1.37bn in its interim results on Thursday, down from £1.46bn at the end of the last financial year.

Read more
3 Sep 2019 08:18

Syncona Provides GBP83 Million In Funding For Two Portfolio Companies

(Alliance News) - Syncona Ltd said Tuesday it has made investments totalling GBP83.1 million in two companies in separate Series B financing rounds.The FTSE 250 healthcare-focused firm made

Read more
3 Sep 2019 07:58

Syncona invests ?83.1m in Gyroscope and Achilles

(Sharecast News) - Syncona on Tuesday confirmed investments of £48.0m in retinal gene therapy group Gyroscope Therapeutic and £35.1m in cancer immunotherapies developer Achilles Therapeutics.

Read more
12 Aug 2019 11:45

CORRECT: Syncona Quarterly Net Asset Value Higher On Blue Earth Sale

(Correcting that the net asset value per share as at March 31 was 216.8p, meaning NAV decreased over the course of the quarter.)(Alliance News) - Healthcare investor Syncona Ltd said its in

Read more
12 Aug 2019 09:30

Syncona Net Asset Value Lifted In First Quarter By Blue Earth Sale

(Alliance News) - Healthcare investor Syncona Ltd said Thursday its net asset value rose in the first quarter of its financial year, despite a drop in the value of its portfolio due to a declining

Read more
9 Aug 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

Monday 12 August ClarksonHalf Year ResultsSynconaQuarterly 13 Year Year

Read more
8 Jul 2019 09:04

Syncona's Freeline Therapeutics Reports Results From Haemophilia Trial

(Alliance News) - Healthcare-focused investment firm Syncona Ltd said Monday that portfolio company Freeline Therapeutics has published 12-month data from an ongoing trial in haemophilia B, and a

Read more
27 Jun 2019 09:47

Syncona Disposes Stake In Blue Earth Diagnostics To Bracco Imaging

(Alliance News) - Investment firm Syncona Ltd on Thursday said it has agreed to sell its portfolio company Blue Earth Diagnostics to Bracco Imaging for USD450 million plus closing adjustment at in

Read more
13 Jun 2019 09:32

Syncona Scraps Dividend To Focus On "Capital Intensive" Portfolio

(Alliance News) - Life sciences investor Syncona Ltd on Thursday reported a "strong" annual performance, with core life sciences firms doing well, while it is also to halt is paying a to

Read more
6 Jun 2019 16:11

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 7 June Seneca Global Income & Growth TrustFull Year ResultsMonday 10 traffic 11

Read more
4 Jun 2019 08:38

Syncona Appoints Investment Banker Melanie Gee As Chair Designate

LONDON (Alliance News) - Healthcare company Syncona Ltd on Tuesday said Melanie Gee will take over the chair of its board from Jeremy Tigue over the coming months in preparation for Tigue's at

Read more
91011121314151617

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.